Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate

Immaculada Ponsa, Josep Antoni Ramos-Quiroga, Marta Ribasés, Rosa Bosch, Anna Bielsa, Maria Teresa Ordeig, Marta Morell, Rosa Miró, Rafael de Cid, Xavier P. Estivill, Miquel Casas, Mònica Bayés, Bru Cormand, Amaia Hervás

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50% of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.] described the induction of chromosome abnormalities by MPH in children treated for three months, contrary to most of the in vitro and in vivo studies reported since then. We present new relevant information concerning the cytogenetic effects of MPH in children and adults. We include a prospective sample of 12 children and 7 adults with a new diagnosis of ADHD and naive to MPH. We analyzed the cytogenetic effects on peripheral lymphocytes before and three months after starting MPH therapy. The cytogenetic analyses included a cytokinesis-block micronucleus (CBMN) assay, a sister chromatid exchange (SCE) analysis and the determination of chromosome aberrations (CA). Following the same strategy and analyzing the same cytogenetic endpoints that were investigated in the original report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.], we found no evidence of increased frequency of micronuclei, sister chromatid exchanges or chromosome aberrations induced by MPH in children and adult populations. MPH treatment of children and adults with ADHD resulted in no significant genomic damage (as suggested by the three endpoints studied), results that do not support a potential increased risk of cancer after exposure to MPH.

Original languageEnglish
Pages (from-to)44-49
Number of pages6
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume666
Issue number1-2
DOIs
Publication statusPublished - 18 Jun 2009
Externally publishedYes

Fingerprint

Methylphenidate
Attention Deficit Disorder with Hyperactivity
Cytogenetics
Chromosome Aberrations
Sister Chromatid Exchange
Neoplasms
Micronucleus Tests
Cytokinesis
Cytogenetic Analysis
Prescriptions
Psychiatry
Lymphocytes

Keywords

  • ADHD
  • Adult
  • Children
  • Cytogenetic effects
  • Methylphenidate

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Health, Toxicology and Mutagenesis

Cite this

Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate. / Ponsa, Immaculada; Ramos-Quiroga, Josep Antoni; Ribasés, Marta; Bosch, Rosa; Bielsa, Anna; Ordeig, Maria Teresa; Morell, Marta; Miró, Rosa; de Cid, Rafael; Estivill, Xavier P.; Casas, Miquel; Bayés, Mònica; Cormand, Bru; Hervás, Amaia.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 666, No. 1-2, 18.06.2009, p. 44-49.

Research output: Contribution to journalArticle

Ponsa, I, Ramos-Quiroga, JA, Ribasés, M, Bosch, R, Bielsa, A, Ordeig, MT, Morell, M, Miró, R, de Cid, R, Estivill, XP, Casas, M, Bayés, M, Cormand, B & Hervás, A 2009, 'Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 666, no. 1-2, pp. 44-49. https://doi.org/10.1016/j.mrfmmm.2009.03.014
Ponsa, Immaculada ; Ramos-Quiroga, Josep Antoni ; Ribasés, Marta ; Bosch, Rosa ; Bielsa, Anna ; Ordeig, Maria Teresa ; Morell, Marta ; Miró, Rosa ; de Cid, Rafael ; Estivill, Xavier P. ; Casas, Miquel ; Bayés, Mònica ; Cormand, Bru ; Hervás, Amaia. / Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2009 ; Vol. 666, No. 1-2. pp. 44-49.
@article{750c418a83124aee9579f923f8e0cedc,
title = "Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate",
abstract = "Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50{\%} of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.] described the induction of chromosome abnormalities by MPH in children treated for three months, contrary to most of the in vitro and in vivo studies reported since then. We present new relevant information concerning the cytogenetic effects of MPH in children and adults. We include a prospective sample of 12 children and 7 adults with a new diagnosis of ADHD and naive to MPH. We analyzed the cytogenetic effects on peripheral lymphocytes before and three months after starting MPH therapy. The cytogenetic analyses included a cytokinesis-block micronucleus (CBMN) assay, a sister chromatid exchange (SCE) analysis and the determination of chromosome aberrations (CA). Following the same strategy and analyzing the same cytogenetic endpoints that were investigated in the original report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.], we found no evidence of increased frequency of micronuclei, sister chromatid exchanges or chromosome aberrations induced by MPH in children and adult populations. MPH treatment of children and adults with ADHD resulted in no significant genomic damage (as suggested by the three endpoints studied), results that do not support a potential increased risk of cancer after exposure to MPH.",
keywords = "ADHD, Adult, Children, Cytogenetic effects, Methylphenidate",
author = "Immaculada Ponsa and Ramos-Quiroga, {Josep Antoni} and Marta Ribas{\'e}s and Rosa Bosch and Anna Bielsa and Ordeig, {Maria Teresa} and Marta Morell and Rosa Mir{\'o} and {de Cid}, Rafael and Estivill, {Xavier P.} and Miquel Casas and M{\`o}nica Bay{\'e}s and Bru Cormand and Amaia Herv{\'a}s",
year = "2009",
month = "6",
day = "18",
doi = "10.1016/j.mrfmmm.2009.03.014",
language = "English",
volume = "666",
pages = "44--49",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate

AU - Ponsa, Immaculada

AU - Ramos-Quiroga, Josep Antoni

AU - Ribasés, Marta

AU - Bosch, Rosa

AU - Bielsa, Anna

AU - Ordeig, Maria Teresa

AU - Morell, Marta

AU - Miró, Rosa

AU - de Cid, Rafael

AU - Estivill, Xavier P.

AU - Casas, Miquel

AU - Bayés, Mònica

AU - Cormand, Bru

AU - Hervás, Amaia

PY - 2009/6/18

Y1 - 2009/6/18

N2 - Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50% of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.] described the induction of chromosome abnormalities by MPH in children treated for three months, contrary to most of the in vitro and in vivo studies reported since then. We present new relevant information concerning the cytogenetic effects of MPH in children and adults. We include a prospective sample of 12 children and 7 adults with a new diagnosis of ADHD and naive to MPH. We analyzed the cytogenetic effects on peripheral lymphocytes before and three months after starting MPH therapy. The cytogenetic analyses included a cytokinesis-block micronucleus (CBMN) assay, a sister chromatid exchange (SCE) analysis and the determination of chromosome aberrations (CA). Following the same strategy and analyzing the same cytogenetic endpoints that were investigated in the original report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.], we found no evidence of increased frequency of micronuclei, sister chromatid exchanges or chromosome aberrations induced by MPH in children and adult populations. MPH treatment of children and adults with ADHD resulted in no significant genomic damage (as suggested by the three endpoints studied), results that do not support a potential increased risk of cancer after exposure to MPH.

AB - Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric condition with onset in childhood, and in more than 50% of cases it persists into adulthood as a chronic disorder. Over five million methylphenidate (MPH) prescriptions were issued in the USA in 2003, mostly for children. A previous report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.] described the induction of chromosome abnormalities by MPH in children treated for three months, contrary to most of the in vitro and in vivo studies reported since then. We present new relevant information concerning the cytogenetic effects of MPH in children and adults. We include a prospective sample of 12 children and 7 adults with a new diagnosis of ADHD and naive to MPH. We analyzed the cytogenetic effects on peripheral lymphocytes before and three months after starting MPH therapy. The cytogenetic analyses included a cytokinesis-block micronucleus (CBMN) assay, a sister chromatid exchange (SCE) analysis and the determination of chromosome aberrations (CA). Following the same strategy and analyzing the same cytogenetic endpoints that were investigated in the original report [R.A. El-Zein, S.Z. Abdel-Rahman, M.J. Hay, M.S. Lopez, M.L. Bondy, D.L. Morris and M.S. Legator Cytogenetic effects in children treated with methylphenidate, Cancer Lett. 230 (2005) 284-291.], we found no evidence of increased frequency of micronuclei, sister chromatid exchanges or chromosome aberrations induced by MPH in children and adult populations. MPH treatment of children and adults with ADHD resulted in no significant genomic damage (as suggested by the three endpoints studied), results that do not support a potential increased risk of cancer after exposure to MPH.

KW - ADHD

KW - Adult

KW - Children

KW - Cytogenetic effects

KW - Methylphenidate

UR - http://www.scopus.com/inward/record.url?scp=65749090418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749090418&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2009.03.014

DO - 10.1016/j.mrfmmm.2009.03.014

M3 - Article

VL - 666

SP - 44

EP - 49

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -